Annual ROA
-43.68%
-26.48%-153.95%
31 December 2023
Summary:
Acrivon Therapeutics Common Stock annual return on assets is currently -43.68%, with the most recent change of -26.48% (-153.95%) on 31 December 2023. During the last 3 years, it has risen by +199.16% (+82.01%). ACRV annual ROA is now -186.61% below its all-time high of -15.24%, reached on 31 December 2021.ACRV ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROA
-43.73%
-0.63%-1.46%
30 September 2024
Summary:
Acrivon Therapeutics Common Stock quarterly return on assets is currently -43.73%, with the most recent change of -0.63% (-1.46%) on 30 September 2024. Over the past year, it has dropped by -13.50% (-44.66%). ACRV quarterly ROA is now -587.58% below its all-time high of -6.36%, reached on 01 December 2021.ACRV Quarterly ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ACRV ROA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -153.9% | -44.7% |
| 3 y3 years | +82.0% | -587.6% |
| 5 y5 years | - | - |
ACRV ROA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -186.6% | +82.0% | -587.6% | +2.8% |
| 5 y | 5 years | -186.6% | +82.0% | -587.6% | +2.8% |
| alltime | all time | -186.6% | +82.0% | -587.6% | +2.8% |
Acrivon Therapeutics Common Stock ROA History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -43.73%(+1.5%) |
| June 2024 | - | -43.10%(-4.2%) |
| Mar 2024 | - | -45.00%(+15.4%) |
| Dec 2023 | -43.68%(+154.0%) | -38.98%(+28.9%) |
| Sept 2023 | - | -30.23%(+1.1%) |
| June 2023 | - | -29.91%(+8.8%) |
| Mar 2023 | - | -27.49%(+7.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | -17.20%(+12.9%) | -25.69%(-6.8%) |
| Sept 2022 | - | -27.56%(+40.1%) |
| June 2022 | - | -19.67%(+49.7%) |
| Mar 2022 | - | -13.14%(+106.6%) |
| Dec 2021 | -15.24%(-93.7%) | - |
| Dec 2021 | - | -6.36% |
| Dec 2020 | -242.84% | - |
FAQ
- What is Acrivon Therapeutics Common Stock annual return on assets?
- What is the all time high annual ROA for Acrivon Therapeutics Common Stock?
- What is Acrivon Therapeutics Common Stock annual ROA year-on-year change?
- What is Acrivon Therapeutics Common Stock quarterly return on assets?
- What is the all time high quarterly ROA for Acrivon Therapeutics Common Stock?
- What is Acrivon Therapeutics Common Stock quarterly ROA year-on-year change?
What is Acrivon Therapeutics Common Stock annual return on assets?
The current annual ROA of ACRV is -43.68%
What is the all time high annual ROA for Acrivon Therapeutics Common Stock?
Acrivon Therapeutics Common Stock all-time high annual return on assets is -15.24%
What is Acrivon Therapeutics Common Stock annual ROA year-on-year change?
Over the past year, ACRV annual return on assets has changed by -26.48% (-153.95%)
What is Acrivon Therapeutics Common Stock quarterly return on assets?
The current quarterly ROA of ACRV is -43.73%
What is the all time high quarterly ROA for Acrivon Therapeutics Common Stock?
Acrivon Therapeutics Common Stock all-time high quarterly return on assets is -6.36%
What is Acrivon Therapeutics Common Stock quarterly ROA year-on-year change?
Over the past year, ACRV quarterly return on assets has changed by -13.50% (-44.66%)